Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees.
Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees.
复制标题
娱乐性大麻合法化与医疗补助参与者处方药使用量的减少相关。
DOI：
10.1002/hec.4519
复制
发表时间：
2022
期刊：
影响因子：
2.1
通讯作者：
Bradford,AshleyC
中科院分区：
文献类型：
--
作者：
Raman,Shyam;Bradford,AshleyC
在医用大麻法律(MCL)的背景下，大麻替代处方药的可能性引起了大量关注。然而，人们对娱乐性大麻法律(RCL)与处方药使用之间的联系知之甚少。随着最近的证据支持在MCL之后用大麻替代处方药，有理由问RCL可能对这些结果有什么影响。我们使用2011至2019年所有医疗补助处方的季度数据来调查州一级RCL对处方药利用的影响。我们使用一系列双向固定效应事件研究模型来估计这一效应。我们发现，与疼痛、抑郁、焦虑、睡眠、精神错乱和癫痫的医学适应症相一致的药物类别中，处方数量显著减少。我们的结果表明，替代处方药和州医疗补助计划的潜在成本节省。
The potential substitution of cannabis for prescription medication has attracted a substantial amount of attention within the context of medical cannabis laws (MCLs). However, much less is known about the association between recreational cannabis laws (RCLs) and prescription drug use. With recent evidence supporting substitution of cannabis for prescription drugs following MCLs, it is reasonable to ask what effect RCLs may have on those outcomes. We use quarterly data for all Medicaid prescriptions from 2011 to 2019 to investigate the effect of state‐level RCLs on prescription drug utilization. We estimate this effect with a series of two‐way fixed effects event study models. We find significant reductions in the volume of prescriptions within the drug classes that align with the medical indications for pain, depression, anxiety, sleep, psychosis, and seizures. Our results suggest substitution away from prescription drugs and potential cost savings for state Medicaid programs.